Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography

被引:154
作者
Patel, Parag [1 ]
Dhillon, Ashwat [1 ]
Popovic, Zoran B. [1 ]
Smedira, Nicholas G. [1 ]
Rizzo, Jessica [1 ]
Thamilarasan, Maran [1 ]
Agler, Deborah [1 ]
Lytle, Bruce W. [1 ]
Lever, Harry M. [1 ]
Desai, Milind Y. [1 ]
机构
[1] Cleveland Clin, Inst Heart & Vasc, Hypertroph Cardiomyopathy Ctr, Cleveland, OH 44195 USA
关键词
cardiomyopathy; hypertrophic; echocardiography; magnetic resonance imaging; mitral valve; multimodal imaging; papillary muscles; surgery;
D O I
10.1161/CIRCIMAGING.115.003132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In patients with hypertrophic cardiomyopathy and left ventricular outflow tract (LVOT) obstruction, but without basal septal hypertrophy, we sought to identify mitral valve (MV) and papillary muscle (PM) abnormalities that predisposed to LVOT obstruction, using echo and cardiac magnetic resonance. Methods and Results-We studied 121 patients with hypertrophic cardiomyopathy hypertrophic cardiomyopathy (age, 49 +/- 17 years; 60% men; 57% on beta-blockers) with a basal septal thickness of <= 1.8 cm who underwent echocardiography (rest+stress) and cine cardiac magnetic resonance. Echo measurements included maximal LVOT gradient (rest/provocable), MV leaflet length (parasternal long, 4 and 3-chamber views), and abnormal chordal attachment to mid/base of anterior MV. Cine cardiac magnetic resonance measurements included basal septal thickness, number/area of PM heads, and bifid PM mobility (in systole and diastole). Mean basal septal thickness, LVOT gradient, and LV ejection fraction were 1.5 +/- 0.3 cm, 72 +/- 54 mm Hg, and 61 +/- 6%, respectively. The number of anterolateral and posteromedial PM heads was 2.7 +/- 0.7 and 2.6 +/- 0.7, respectively. Anterolateral and posteromedial PM areas were 19.9 +/- 7 cm(2) and 17.1 +/- 6 cm(2), respectively. PM mobility was 11 +/- 6 degrees. On multivariable analysis, predictors of maximal LVOT gradient were basal septal thickness, bifid PM mobility, anterior mitral leaflet length, and abnormal chordal attachment to base of anterior mitral leaflet. Forty-five patients underwent surgery to relieve LVOT obstruction, of which 52% needed an additional nonmyectomy (MV repair/replacement or PM reorientation) approach. Conclusions-In hypertrophic cardiomyopathy patients without significant LV hypertrophy, in addition to basal septal thickness, anterior MV length, abnormal chordal attachment, and bifid PM mobility are associated with LVOT obstruction. In such patients, additional procedures on MV and PM (+/- myectomy) could be considered.
引用
收藏
页数:10
相关论文
共 33 条
[1]   Abnormally Thickened Papillary Muscle Resulting in Dynamic Left Ventricular Outflow Tract Obstruction: An Unusual Presentation of Hypertrophic Cardiomyopathy [J].
Austin, Bethany A. ;
Kwon, Deborah H. ;
Smedira, Nicholas G. ;
Thamilarasan, Maran ;
Lever, Harry M. ;
Desai, Milind Y. .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (01) :105.e5-105.e6
[2]   Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations [J].
Binder, J ;
Ommen, SR ;
Gersh, BJ ;
Van Driest, SL ;
Tajik, AJ ;
Nishimura, RA ;
Ackerman, MJ .
MAYO CLINIC PROCEEDINGS, 2006, 81 (04) :459-467
[3]   Exercise Echocardiography in Asymptomatic HCM [J].
Desai, Milind Y. ;
Bhonsale, Aditya ;
Patel, Parag ;
Naji, Peyman ;
Smedira, Nicholas G. ;
Thamilarasan, Masan ;
Lytle, Bruce W. ;
Lever, Harry M. .
JACC-CARDIOVASCULAR IMAGING, 2014, 7 (01) :26-36
[4]   Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction [J].
Desai, Milind Y. ;
Bhonsale, Aditya ;
Smedira, Nicholas G. ;
Naji, Peyman ;
Thamilarasan, Maran ;
Lytle, Bruce W. ;
Lever, Harry M. .
CIRCULATION, 2013, 128 (03) :209-216
[5]   Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy [J].
Desai, Milind Y. ;
Ommen, Steve R. ;
McKenna, William J. ;
Lever, Harry M. ;
Elliott, Perry M. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2011, 4 (02) :156-168
[6]   Hypertrophic cardiomyopathy [J].
Elliott, P ;
McKenna, WJ .
LANCET, 2004, 363 (9424) :1881-1891
[7]   Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy [J].
Elliott, Perry M. ;
Gimeno, Juan R. ;
Tome, Maria T. ;
Shah, Jaymin ;
Ward, Deirdre ;
Thaman, Rajesh ;
Mogensen, Jens ;
McKenna, William J. .
EUROPEAN HEART JOURNAL, 2006, 27 (16) :1933-1941
[8]   2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Gersh, Bernard J. ;
Maron, Barry J. ;
Bonow, Robert O. ;
Dearani, Joseph A. ;
Fifer, Michael A. ;
Link, Mark S. ;
Naidu, Srihari S. ;
Nishimura, Rick A. ;
Ommen, Steve R. ;
Rakowski, Harry ;
Seidman, Christine E. ;
Towbin, Jeffrey A. ;
Udelson, James E. ;
Yancy, Clyde W. .
CIRCULATION, 2011, 124 (24) :E783-U84
[9]   Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy [J].
Harrigan, Caitlin J. ;
Appelbaum, Evan ;
Maron, Barry J. ;
Buros, Jacqueline L. ;
Gibson, C. Michael ;
Lesser, John R. ;
Udelson, James E. ;
Manning, Warren J. ;
Maron, Martin S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05) :668-673
[10]   SURGICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - EARLY AND LATE RESULTS [J].
HERIC, B ;
LYTLE, BW ;
MILLER, DP ;
ROSENKRANZ, ER ;
LEVER, HM ;
COSGROVE, DM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :195-208